Showing results (2061-2070 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.
Drug Safety|April 9, 2025
Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson's Disease Psychosis: An UpdateSapna Rao, Lisa J McQuay, Joan Forns, et al.
Drug Safety|April 16, 2025
Signal Monitoring for Adverse Events Following Immunisation with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance SystemChenoa Sankar, Stephen Evans, Johanna Catharina Meyer, et al.
Drug Safety|September 16, 2025
Managing Drug Interactions with Enzalutamide in Patients with Prostate Cancer: A PodcastAlicia K Morgans, Brooke Looney, Jesse Mack, et al.
Drug Safety|September 13, 2025
Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic ReviewMelanie H Jacobson, Meritxell Sabidó, Ana Sofia Afonso, et al.
Drug Safety|August 20, 2025
External Comparator Studies: Performance of Four Missing Data-Handling Approaches, Stratified by Four Different Marginal EstimatorsGerd Rippin, Héctor Sanz, Wilhelmina E Hoogendoorn, et al.
Drug Safety|September 16, 2025
Implied ADR-Admissions: A Cohort Study Introducing a Novel Administrative Data Approach for Identifying Drug-Related HospitalisationsMiriam Schechner, Marietta Rottenkolber, Clara Weglage, et al.
Drug Safety|October 14, 2025
Systematic Review Examining the Effectiveness of Professional, Organisational and Structural Interventions in Primary Care to Reduce Medication-Related Hospitalisations and DeathsHanan Khalil, Brian G Bell, Richard N Keers, et al.
Drug Safety|August 1, 2014
Association between statin use and Bell's palsy: a population-based studyShih-Han Hung, Li-Hsuan Wang, Herng-Ching Lin, et al.
Drug Safety|August 7, 2014
Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort studyYing He, Esther W Chan, Kenneth K C Man, et al.
Pageof 311